National Institutes of Health (NIH): Intramural Research Program (IRP)

What National Institutes of Health (NIH): Intramural Research Program (IRP) does

The NIH Intramural Research Program (IRP), formally established in 1946 as the internal research arm of the National Institutes of Health, is a U.S. federal biomedical research enterprise headquartered in Bethesda, Maryland, that traces its origins to the 1887 Hygienic Laboratory. The IRP conducts fundamental and translational biomedical research across 24 NIH institutes and centers — including NCI, NIAID, NHLBI, NIMH, NINDS, and the NIH Clinical Center — employing approximately 722 staff and engaging hundreds of principal investigators organized across 22 scientific focus areas from cancer biology to virology. Core technologies include MRI and functional MRI, differential tractography, two-photon microscopy, gene therapy platforms, supercomputing, and AI/ML algorithms applied to genomic, imaging, and clinical data.

The IRP is not a commercial entity and does not generate revenue in the traditional sense; it is funded through congressional appropriations to NIH as part of the federal budget, and clinical research services at the NIH Clinical Center are provided at no cost to eligible participants. Its primary end-users are patients with rare and complex diseases seeking experimental treatments and biomedical researchers requiring access to specialized facilities, while intellectual property is monetized through technology transfer licensing to pharmaceutical and biotech companies. Research outputs are distributed through peer-reviewed publications, clinical guidelines, public health applications, and an active science-communication platform that includes the Speaking of Science Podcast, SciBites Video Shorts, the I am Intramural Blog, and the NIH Catalyst Newsletter.

The IRP operates the NIH Clinical Center — the world's largest research hospital dedicated entirely to clinical research — enabling direct bench-to-bedside translation across gene therapy (e.g., a GM1 gangliosidosis treatment now in Phase 1/2 trials), neuroimaging biomarkers, addiction therapeutics (including a Pfizer-partnered ghrelin receptor antagonist for alcohol use disorder), and bone regeneration research. The organization has produced 5 Nobel Prize winners and elected four scientists to the National Academy of Sciences in April 2025. Recent strategic activity centers on AI/ML capability expansion (quantum genomics, predictive analytics, computer vision), with leadership transitions at NCI and NCCIH announced in 2025.

Name

National Institutes of Health (NIH): Intramural Research Program (IRP)

Legal name

National Institutes of Health (NIH): Intramural Research Program (IRP)

Website

https://irp.nih.gov

Company type

Private

Founded year

1946

Operating status

Operating

Headcount range

501–1,000 employees

Short description

The NIH Intramural Research Program conducts fundamental and translational biomedical research across 24 NIH institutes, employing 722 staff and hundreds of principal investigators to advance treatments for cancer, neurological diseases, addiction, and rare disorders through the NIH Clinical Center and federally funded research infrastructure.

Ownership category

akta.pro rank

Product category

Government Biomedical Research

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Professional, Scientific, and Technical Services (54)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Public Research Universities with National Laboratories/Big Science Facilities (EDAHAAAJ)

akta.pro secondary industries

Clinical Research & Trial Central Laboratories (HLAFAMAL), Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD), Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)

Keywords

• Biomedical research
• Clinical research
• Translational science
• Genomic medicine
• Health research training

Headquarters

HQ city

Bethesda

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations

Distribution channels3 records

Marketing channels10 records

Core offering

The NIH IRP conducts fundamental and clinical biomedical research across 24 NIH Institutes and Centers, operating the NIH Clinical Center (the world's largest hospital dedicated entirely to clinical research) and hundreds of research laboratories. Its core offerings include intramural laboratory research, clinical trials for rare and complex diseases, advanced imaging and gene therapy capabilities, research training programs, and technology transfer of patented discoveries to pharmaceutical and biotech partners.

Product overview

The NIH Intramural Research Program (IRP) is a premier biomedical research environment where scientists conduct fundamental research for human health improvement. Rather than a commercial product company, the IRP offers a portfolio of scientific resources and content platforms including: SciBites video shorts for public science communication, the I am Intramural Blog for researcher stories, the Speaking of Science Podcast for in-depth conversations, and The NIH Catalyst newsletter for research updates. The program operates the NIH Clinical Center for clinical research, maintains a directory of over 1,000 Principal Investigators across 22 scientific focus areas, and provides Research Training Programs for developing scientists. The IRP encompasses 24 NIH Institutes and Centers conducting collaborative biomedical research.

Differentiator

Problem solved

Functional benefit

Brands

• Speaking of Science Podcast: IRP's podcast featuring conversations with world-leading researchers working on challenges across the spectrum of biomedicine.
• SciBites Video Shorts
• I am Intramural Blog
• The NIH Catalyst Newsletter

Products and services

• NIH Clinical Center

Quantifiable outcome

• Four IRP scientists were elected to the National Academy of Sciences in April 2025
• +3 more outcomes

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability10 records

Feature4 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Suburban HospitalcoreStrategic or Co-development Partner · 1 January 2000The Acute Cerebrovascular Diagnostics Unit is a partnership between the IRP and Suburban Hospital, incorporating MRI in examinations of patients experiencing stroke symptoms to improve diagnosis and treatment outcomes.
• Medstar Washington Hospital CentercoreStrategic or Co-development Partner · 1 January 2000Partnership with Medstar Washington Hospital Center in the Acute Cerebrovascular Diagnostics Unit, allowing IRP researchers to study stroke patients using advanced MRI imaging techniques.
• Auburn UniversitycoreStrategic or Co-development PartnerCollaborated with Auburn University researchers to develop a gene therapy for GM1 gangliosidosis that delivers a normal copy of the GLB1 gene to patients.
• University of Massachusetts Chan Medical SchoolcoreStrategic or Co-development PartnerCo-developed gene therapy for GM1 gangliosidosis with researchers at UMass Chan Medical School, currently in Phase 1/2 clinical trial at NIH.
• PfizercoreStrategic or Co-development PartnerCollaborated with Pfizer to test a ghrelin receptor antagonist (PF-5190457) for potential treatment of alcohol use disorder, leveraging NIH grant program to partner with pharmaceutical companies.
• University of Rhode IslandminorStrategic or Co-development PartnerJoint research with University of Rhode Island researchers to study ghrelin receptor antagonists for alcohol use disorder treatment.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• INSERM (French National Institute of Health and Medical Research): France's national public biomedical research agency — the European equivalent of NIH's extramural/intramural portfolio. Comparable in being a state-funded national medical research organization spanning basic, clinical, and translational research across multiple institutes.
• The Francis Crick Institute: The largest single biomedical research institute in Europe, housing 1,500+ scientists in a purpose-built facility. Closest international analog to NIH IRP — a government-funded, multi-disciplinary biomedical research campus driving fundamental and translational discovery.
• MRC Laboratory of Molecular Biology (LMB): UK Research Council-funded biomedical research lab with the highest Nobel density per square meter in history. Comparable to NIH IRP as a publicly funded, government-supported basic biomedical research institute producing breakthrough structural and molecular biology.
• Wellcome Sanger Institute: Genomics and bioinformatics research institute funded by the Wellcome Trust. Comparable to NIH IRP's NHGRI-aligned genomics work and similar in mission of generating large-scale, publicly available biomedical data resources.
• The Rockefeller University: Private graduate biomedical research university with extreme concentration of Nobel laureates and clinical research capacity (Rockefeller Hospital). Closely comparable to NIH IRP's Clinical Center in supporting bench-to-bedside research in a single institution.
• Broad Institute of MIT and Harvard: Joint MIT/Harvard research institute specializing in genomics, chemical biology, and disease-focused translational science. Comparable to NIH IRP in scale, interdisciplinary research model, and integration of computational/AI methods with bench biology.
• The Salk Institute for Biological Studies: Elite non-profit basic research institute with ~850 researchers focused on cancer, neuroscience, immunology, and plant biology. Comparable to NIH IRP in producing Nobel-caliber fundamental science, though smaller and narrower in disciplinary scope.
• Scripps Research: Top-tier non-profit biomedical research organization with strong programs in chemistry, structural biology, and immunology. Comparable to NIH IRP in producing fundamental discoveries and training the next generation of biomedical scientists.
• Howard Hughes Medical Institute (HHMI): The largest private U.S. biomedical research organization, supporting hundreds of investigators across HHMI-affiliated institutions. Directly comparable to NIH IRP in mission, scale, talent caliber, and Nobel-class output, but funded by a private endowment rather than federal appropriations.

Emerging players

• Allen Institute: Non-profit medical research organization focused on brain science, cell science, and immunology. Comparable to NIH IRP in scale of AI-driven biomedical research but more focused on large-scale atlasing projects than hypothesis-driven investigator-initiated science.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/IRPatNIH
• YouTubeyoutube.com/user/IRPNIH
• Facebookfacebook.com/sharer.php
• LinkedInlinkedin.com/company/intramural-research-program-irp
• Instagraminstagram.com/irpatnih

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about National Institutes of Health (NIH): Intramural Research Program (IRP)